NCT06267131

Brief Summary

This is a study of adult patients with a severe and sudden brain injury who have a drain placed in their brain to measure pressure. The purpose of the study is to monitor the pressure in the brain using a monitor placed on the forehead, and compare this to a drain placed in the brain.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 27, 2023

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

November 8, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 20, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

February 20, 2024

Status Verified

February 1, 2024

Enrollment Period

1 year

First QC Date

November 8, 2023

Last Update Submit

February 18, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Agreement of the brain oximeter levels compared with invasive ICP levels

    Correlation of the optical signal waveforms with the invasive ICP waveforms and level

    Daily recordings for up to 30 days while the patient has an invasive ICP probe in situ

Secondary Outcomes (2)

  • Optical signal changes associated with periods of brain hypoxia and surrogate ICP waveform

    Daily recordings for up to 30 days while the patient has an invasive ICP probe in situ

  • Optical signal changes associated with non-convulsive seizures via EEG monitoring (Alpha, Beta, Theta)

    Daily recordings for up to 30 days while the patient has an invasive ICP probe in situ

Study Arms (1)

Enrolled patients

OTHER

All enrolled patients will have brain pulse monitoring

Device: Brain Pulse Oximeter

Interventions

Sensor is placed on the right and/or left forehead and maintained with an elasticized headband. The duration of monitoring will last for approximately 60 minutes per monitoring session to obtain sufficient data. Serial monitoring will occur on three consecutive days.

Enrolled patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Adult brain-injured patients who have undergone external ventricular drain insertion for cerebrospinal fluid drainage and invasive intracranial pressure monitoring as part of standard medical care
  • \. Adult brain-injured patients who have undergone external ventricular drain insertion for cerebrospinal fluid drainage and invasive intracranial pressure monitoring that have concomitant continuous electroencephalography (EEG) monitoring as part of standard medical care

You may not qualify if:

  • \. Inability to obtain the brain pulse oximeter signal from at least one brain hemisphere due to interface issue such as severe agitation, head dressing, severe skin or bone trauma, or skull removal preventing brain pulse detection for the initial monitoring session.
  • a. Note: If unable to obtain brain pulse oximeter signal for subsequent monitoring sessions, the only the recordings that were obtained will be used for analysis
  • \. Hemodynamically unstable patients (defined as increasing vasopressors requirements)
  • \. Patients with unstable mechanical ventilation support defined as increasing fractional inspired oxygen (FiO2) requirements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic, Neurological Institute

Cleveland, Ohio, 44195, United States

RECRUITING

MeSH Terms

Conditions

Brain Injuries

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Catherine Hassett, DO

    The Cleveland Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Catherine Hassett, DO

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Single center prospective observational cohort study
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 8, 2023

First Posted

February 20, 2024

Study Start

October 27, 2023

Primary Completion

November 1, 2024

Study Completion

November 1, 2024

Last Updated

February 20, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations